New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for ...

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with ...
Public Broadcasting Service (PBS)

Under new guidelines, more Americans meet the criteria for high blood pressure

The new guidelines released by the American Heart Association and the American College of Cardiology lower the threshold for ...